DE2537070C2 - - Google Patents

Info

Publication number
DE2537070C2
DE2537070C2 DE2537070A DE2537070A DE2537070C2 DE 2537070 C2 DE2537070 C2 DE 2537070C2 DE 2537070 A DE2537070 A DE 2537070A DE 2537070 A DE2537070 A DE 2537070A DE 2537070 C2 DE2537070 C2 DE 2537070C2
Authority
DE
Germany
Prior art keywords
general formula
carboxylic acid
hydroxy
thiophene
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2537070A
Other languages
German (de)
English (en)
Other versions
DE2537070A1 (de
Inventor
Otto Prof. Dr. Hromatka
Dieter Dr. Wien At Binder
Rudolf Dr. Basel Ch Pfister
Paul Dr. Allschwil Ch Zeller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F HOFFMANN-LA ROCHE and Co AG BASEL CH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1158274A external-priority patent/CH608500A5/de
Priority claimed from CH1215774A external-priority patent/CH608501A5/de
Application filed by F HOFFMANN-LA ROCHE and Co AG BASEL CH filed Critical F HOFFMANN-LA ROCHE and Co AG BASEL CH
Publication of DE2537070A1 publication Critical patent/DE2537070A1/de
Application granted granted Critical
Publication of DE2537070C2 publication Critical patent/DE2537070C2/de
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Electroplating Methods And Accessories (AREA)
DE19752537070 1974-08-26 1975-08-20 Thiazinderivate Granted DE2537070A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1158274A CH608500A5 (en) 1974-08-26 1974-08-26 Process for the preparation of thiazine derivatives
CH1215774A CH608501A5 (en) 1974-09-09 1974-09-09 Process for the preparation of thiazine derivatives

Publications (2)

Publication Number Publication Date
DE2537070A1 DE2537070A1 (de) 1976-03-18
DE2537070C2 true DE2537070C2 (fr) 1987-06-25

Family

ID=25708582

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752537070 Granted DE2537070A1 (de) 1974-08-26 1975-08-20 Thiazinderivate

Country Status (20)

Country Link
JP (1) JPS5826758B2 (fr)
AR (1) AR216288A1 (fr)
AT (1) AT350064B (fr)
BR (1) BR7505463A (fr)
DD (1) DD124119A5 (fr)
DE (1) DE2537070A1 (fr)
DK (1) DK137835B (fr)
FI (1) FI59253C (fr)
FR (3) FR2282893A1 (fr)
GB (1) GB1519811A (fr)
HU (1) HU173739B (fr)
IE (1) IE41457B1 (fr)
IL (1) IL47877A (fr)
LU (2) LU73257A1 (fr)
NL (2) NL183582C (fr)
NO (1) NO146096C (fr)
PL (1) PL106076B1 (fr)
SE (1) SE412066B (fr)
SU (1) SU603338A3 (fr)
YU (1) YU40266B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704485A1 (de) * 1977-02-03 1978-08-10 Thomae Gmbh Dr K Neue 2,5-dihydro-1,2-thiazino eckige klammer auf 5,6-b eckige klammer zu indol-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
LU78009A1 (de) * 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
ZA784958B (en) * 1977-09-06 1979-08-29 Hoffmann La Roche Thiazine derivatives
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
JPS58109492A (ja) * 1981-12-22 1983-06-29 Mitsui Toatsu Chem Inc チエノチアジン誘導体およびそれを含有する医薬組成物
ATE26720T1 (de) * 1982-09-09 1987-05-15 Hoffmann La Roche Thieno(2,3-e)-1,2-thiazin-derivate.
JPS60163533U (ja) * 1984-04-02 1985-10-30 ホシデン株式会社 リ−ル台の制動装置
JPH0318748Y2 (fr) * 1985-12-18 1991-04-19
ATA39088A (de) 1988-02-18 1990-06-15 Binder Dieter Dr Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung
AT400568B (de) * 1994-05-18 1996-01-25 Chem Pharm Forsch Gmbh Neue n-heterocyclische thienothiazincarboxamide, verfahren zu ihrer herstellung und ihre verwendung
AT400437B (de) * 1993-12-14 1995-12-27 Chem Pharm Forsch Gmbh Neue n-heterocyclische thienothiazincarboxamide, verfahren zu ihrer herstellung und ihre verwendung
EP0658559A1 (fr) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Dérivés thiénothianine, procédé pour leur préparation et leur application comme inhibiteurs de 5-dipoxygenase et cyclooxygenase
US5538966A (en) * 1994-01-21 1996-07-23 Alcon Laboratories, Inc. Carbonic anhydrase inhibitors
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
CN1171892C (zh) * 2001-06-25 2004-10-20 李晶 具有抗炎镇痛活性的噻吩并噻嗪化合物及其制备方法和用途

Also Published As

Publication number Publication date
DK381175A (fr) 1976-02-27
NO752932L (fr) 1976-02-27
DD124119A5 (fr) 1977-02-02
AT350064B (de) 1979-05-10
AU8418675A (en) 1977-02-24
FI59253B (fi) 1981-03-31
HU173739B (hu) 1979-08-28
FI752398A (fr) 1976-02-27
DK137835C (fr) 1978-10-16
SU603338A3 (ru) 1978-04-15
FR2282893B1 (fr) 1980-05-16
FI59253C (fi) 1981-07-10
DK137835B (da) 1978-05-16
IL47877A (en) 1978-10-31
LU73257A1 (fr) 1977-04-15
FR2303803A1 (fr) 1976-10-08
JPS5826758B2 (ja) 1983-06-04
YU216675A (en) 1982-08-31
IE41457B1 (en) 1980-01-02
LU88312I2 (de) 1994-09-09
NL183582C (nl) 1988-12-01
IE41457L (en) 1976-02-26
IL47877A0 (en) 1975-11-25
FR2303803B1 (fr) 1979-07-13
NL183582B (nl) 1988-07-01
ATA655975A (de) 1978-10-15
SE412066B (sv) 1980-02-18
YU40266B (en) 1985-12-31
NL930080I1 (nl) 1993-09-16
GB1519811A (en) 1978-08-02
FR2309558B1 (fr) 1979-05-04
NO146096B (no) 1982-04-19
SE7509446L (sv) 1976-02-27
BR7505463A (pt) 1976-08-03
AR216288A1 (es) 1979-12-14
NO146096C (no) 1982-07-28
JPS5148694A (fr) 1976-04-26
FR2282893A1 (fr) 1976-03-26
NL930080I2 (nl) 1994-01-03
FR2309558A1 (fr) 1976-11-26
PL106076B1 (pl) 1979-11-30
DE2537070A1 (de) 1976-03-18
NL7510057A (nl) 1976-03-01

Similar Documents

Publication Publication Date Title
DE2705446C2 (fr)
DE2537070C2 (fr)
DE2812625C2 (fr)
DE1595915A1 (de) Verfahren zur Herstellung von heterocyclischen Benzamiden
EP0041215B1 (fr) Imidazoazolalkénylcarboxamides, intermédiaires pour leur préparation, leur préparation et leur application comme médicaments
EP0021207B1 (fr) Alphacarbamoyle-pyrrolpropionitriles, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0103142B1 (fr) Dérivés de thiéno(2,3-e)-1,2-thiazine
DD151445A5 (de) Verfahren zur herstellung von alpha,alpha,alpha-trifluor(aminoaryl)-aethanolen,estern und aethern
EP0156091B1 (fr) Bêta-oxo-alpha-carbamoyl-pyrrolpropionitriles, procédés de leur préparation, composés les contenant et leur utilisation thérapeutique
DE1493797B2 (de) Verfahren zur Herstellung von neuen substituierten Malonsäuremonohydraziden
DE3020421A1 (de) Imidazoazolalkensaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln
DE2706859A1 (de) Thiazinderivate
DE2030714A1 (de) Neue tricychsche Verbindungen und Verfahren zu ihrer Herstellung
EP0148742B1 (fr) Dérivés de 2-(2-thiényl)-imidazo[4,5-b]pyridine, sels d'addition d'acide pharmaceutiquement compatibles et procédé pour leur préparation
DE2360329A1 (de) 1,7-dialkyl-1,2-dihydro-4-hydroxy-1,8naphthyridin-3-carbonsaeurealkylester
AT354432B (de) Verfahren zur herstellung von 3-indolylessig- saeuren
AT371457B (de) Verfahren zur herstellung von neuen 6-substituierten pyranon-verbindungen
AT222124B (de) Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe
DE3028291A1 (de) 3-methylbenzo eckige klammer auf b eckige klammer zu furyl-2-acetamide und ihre verwendung als muskelrelaxantien
EP0021058A2 (fr) Dérivés de la benzothiénothiazine, leur application, procédé et intermédiaires pour leur préparation et médicaments les contenant
DE3217446A1 (de) Substituierte thiocarbamoyl-thenoylacetonitrile, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
CH621791A5 (en) Process for the preparation of thienothiazine derivatives
DE936210C (de) Verfahren zur Herstellung von heterocyclischen Kondensations-produkten und ihren Salzen
AT365200B (de) Verfahren zur herstellung von neuen thienothiazin-derivaten und von deren salzen
AT330779B (de) Verfahren zur herstellung von neuen chinolinessigsaurederivaten und ihren salzen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: F. HOFFMANN-LA ROCHE AG, BASEL, CH

8328 Change in the person/name/address of the agent

Free format text: LEDERER, F., DIPL.-CHEM. DR., 8000 MUENCHEN RIEDERER FRHR. VON PAAR ZU SCHOENAU, A., DIPL.-ING., PAT.-ANWAELTE, 8300 LANDSHUT